Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States

Figure 1 Study overview. Flow diagram detailing patient record selection process. ECOG: Eastern Cooperative Oncology Group; EMR: Electronic medical record.

Figure 2 Therapeutic sequences. Sankey plot detailing subsequent treatments received by patients.

Figure 3 Real-world progression-free survival and overall survival. A: Kaplan-Meier plot of Real-world progression-free survival (rwPFS), median rwPFS (88 d) is shown as a dashed line; B: Kaplan-Meier plot of overall survival (OS), median OS (258 d) is shown as a dashed line.